Israel: Covid drug saves 47 of 50 severe patients in trial
Bonus BioGroup says its MesenCure experimental treatment resulted in 94% survival rate of trial subjects and cut hospitalization time in…
Israel: Trials with approved drug give ‘astounding results’ in severe COVID cases
A year ago, an Israeli research team believed that a drug on the market since 1975 could reduce the threat…